[2018] UGHCCD 104

[2018] UGHCCD 104

The court found that the National Drug Authority Licensing Guidelines, 2017 and 2018 were made by the Secretariat and not by the Authority or Minister as required by the National Drug Policy and Authority Act. There was no evidence of proper delegation of the power to make such guidelines. The guidelines imposed...

Source-derived case information.

Citation
[2018] UGHCCD 104
Parties
Applicant: Petnum Pharmacy Limited; Respondent: National Drug Authority
Court
HC: Civil Division (Uganda)
Jurisdiction
Uganda
Case Number
MISCELLANEOUS CAUSE NO.56 OF 2018
Procedural Posture
Miscellaneous Cause / Ruling on Judicial Review Application
Outcome
Application allowed. Guidelines and impugned decisions quashed. Mandamus issued. Damages and costs awarded to applicant.
Judges
Musa Ssekaana, J
Legal Topics
Judicial Review, Ultra Vires, Licensing of Pharmacies, Subsidiary Legislation, Misfeasance in Public Office
Source Language
en
Administrative Law Commercial and Corporate Judicial Review Ultra Vires Licensing of Pharmacies Subsidiary Legislation Misfeasance in Public Office

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Downloadable case file Legal principles 5 Authorities cited 17 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Petnum Pharmacy Limited

Applicant

National Drug Authority

Respondent

Procedural Posture

Miscellaneous Cause / Ruling on Judicial Review Application

  1. 1 Whether the National Drug Authority Licensing Guidelines, 2017 and 2018 are illegal and/or ultra vires.
  2. 2 Whether the respondent's decisions regarding distance guidelines for location of pharmacies as communicated to the applicant are illegal and/or ultra vires.
  3. 3 What remedies are available to the applicant.

Ratio Decidendi

The court found that the National Drug Authority Licensing Guidelines, 2017 and 2018 were made by the Secretariat and not by the Authority or Minister as required by the National Drug Policy and Authority Act. There was no evidence of proper delegation of the power to make such guidelines. The guidelines imposed distance requirements for pharmacy locations not provided for in the parent Act or regulations, making them ultra vires. Consequently, all decisions made by the respondent based on these guidelines, including the refusal to issue a certificate of suitability of premises to the applicant, were illegal and void. The court also held that the applicant had locus standi to bring the...

Court Disposition

Application allowed. Guidelines and impugned decisions quashed. Mandamus issued. Damages and costs awarded to applicant.

Orders

  • The National Drug Authority Licensing Guidelines, 2017 and 2018 are quashed for illegality.
  • The respondent's decisions based on the impugned guidelines are quashed.